Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Apr 17:15:205-208.
doi: 10.2147/IMCRJ.S358084. eCollection 2022.

Severe Carbamazepine Toxicity Treated with Continuous Venovenous Hemofiltration at Palestine Medical Complex: Two Case Reports

Affiliations
Case Reports

Severe Carbamazepine Toxicity Treated with Continuous Venovenous Hemofiltration at Palestine Medical Complex: Two Case Reports

Mowaffaq A Nasif et al. Int Med Case Rep J. .

Abstract

Carbamazepine intoxication is not uncommon and accounts for many cases of poisoning among anticonvulsive medications users. Since there is no specific antidote for carbamazepine overdose, management is limited to gastric decontamination and supportive therapy. With its high protein binding, the role of extracorporeal elimination in carbamazepine intoxication is still questionable. Here two cases of severe carbamazepine intoxication are presented; the cases were brought to the emergency department after the ingestion of 12,000 mg of controlled release carbamazepine for the first case, and unknown amounts of the same drug for the second case. Both cases were presented with altered mental status, convulsion, and high serum carbamazepine levels of more than 20 mcg/mL. They were intubated and treated with continuous venovenous hemofiltration, after which carbamazepine levels declined significantly along with subsequent clinical improvement and complete neurological recovery. Both cases were discharged home for further psychiatric care.

Keywords: carbamazepine; continuous renal replacement therapy; poisoning.

PubMed Disclaimer

Conflict of interest statement

The authors state that they do not present any conflict of interests.

References

    1. Maan JS, Duong T, Saadabadi A. Carbamazepine. Essence Analg Analg. 2021;1:301–305. doi:10.1017/CBO9780511841378.073 - DOI
    1. Ghannoum M, Yates C, Galvao TF, et al. Extracorporeal treatment for carbamazepine poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin Toxicol. 2014;52(10):993–1004. doi:10.3109/15563650.2014.973572 - DOI - PMC - PubMed
    1. Gummin DD, Mowry JB, Spyker DA, et al. 2018 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 36th Annual Report. Clin Toxicol. 2019;57(12):1220–1413. doi:10.1080/15563650.2019.1677022 - DOI - PubMed
    1. Gummin DD, Mowry JB, Beuhler MC, et al. 2019 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 37th Annual Report. Clin Toxicol. 2020;58(12):1360–1541. doi:10.1080/15563650.2020.1834219 - DOI - PubMed
    1. Al KY, Sekhon S, Jain S. Carbamazepine Toxicity. Pediatr Neurol Briefs. 2021;4(4):31.

Publication types